Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune® Oral Solution (Cyclosporine Oral Solution, USP), 100 mg/...
Summary Company Announcement Date: November 24, 2023 FDA Publish Date: November 27, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to crystallization formation Company Name: Novartis Pharmaceuticals Corporation Brand Name: …